Skip to main content
. 2022 Jan 10;14(1):47. doi: 10.3390/toxins14010047
AE augmentation enterocystoplasty
AUA/SUFU American Urological Association/Society of Urodynamics
BCI bladder contractility index
BoNT-A Botulinum neurotoxin A
CBC cystometric bladder capacity
CIC clean intermittent catheterization
DSD detrusor sphincter dyssynergia
FDA Food and Drug Administration
FS first desire to void
FSF first sensation of bladder filling
LUTD lower urnary tract dysfunction
NBSS neurogenic bladder symptoms score
NDO neurogenic detrusor overactivity
Pdet.Qmax deterusor pressure at maximal flow rate
PVR post-void residual urine
Qmax maximal flow rate
QoL quality of life
SCI spinal cord injury
UTIs urinary tract infections
US urgency sensation
VE voiding efficiency
VUDS video-urodynamic study